证券代码：603108 证券简称：润达医疗 公告编号：临2025-063 转债代码：113588 转债简称：润达转债 上海润达医疗科技股份有限公司 关于增加2025年度日常关联交易预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 因公司业务发展的需要，依据实际情况，增加与关联方2025年度日常关联交易预计的金额。 ● 本次日常关联交易不会导致公司对关联方形成依赖，不会影响上市公司的独立性。 ● 本次增加的日常关联交易金额在公司董事会审批范围之内，无需提交股东会审议。 一、增加日常关联交易履行的审议程序 2024年12月4日，公司第五届董事会第十九次会议审议通过了《关于公司2025年度日常关联交易预计的 议案》，关联董事回避表决。该议案经过公司2024年第三次临时股东大会审议通过，关联股东回避表 决。2025年内，公司经过第五届董事会第二十三次会议及第五届董事会第二十四次会议审议，分别通过 了《关于增加2025年度日常关联交易预计的议案》，关联董事回避表决。 2025年12月26日，公司第五届董事会 ...

Core Viewpoint - The implementation of the "15-minute health service circle" in Chongqing's Yunyang County aims to provide high-quality and convenient health services to residents, transforming a public welfare vision into practical action [1][2]. Group 1: Health Service Development - Yunyang County government focuses on a "people-centered health" goal, optimizing grassroots medical networks as part of the overall county development plan [1]. - The county is directing medical resources to underserved areas based on actual health needs, aiming to create an integrated grassroots medical service system that is efficient, continuous, and equitable [1]. Group 2: Medical Resource Optimization - The establishment of a tightly-knit county medical community, led by the county hospital, enhances collaboration with community health service centers, facilitating effective resource utilization and smooth tiered medical services [1]. - A dual referral system allows for timely upward referrals of complex cases and smooth downward transitions for patients in recovery, reinforcing the role of grassroots initial diagnosis [1]. Group 3: Service Accessibility Improvements - The Qinglong Community Hospital outpatient department has extended service hours until 8:30 PM and aligned chronic disease medication lists with county hospitals, streamlining processes for chronic disease follow-ups and health screenings [1]. - Initiatives like home care services for the disabled and innovative health points exchange activities have engaged over a thousand residents in proactive health management [2]. Group 4: Systematic and Humanized Service - The effective operation of the "15-minute health service circle" demonstrates that systematic planning, standardized support, and humanized services can activate grassroots medical services, making it feasible for minor illnesses to be treated within the community [2].

Core Viewpoint - The National Health Commission of China is implementing various public health service projects aimed at addressing urgent health issues faced by the public, with significant progress reported in multiple areas by 2025 [1] Group 1: Pediatric Services - All 4,845 secondary and tertiary public general hospitals in China now provide pediatric services, enhancing accessibility and capacity for child healthcare [2] Group 2: Mental Health Services - The national psychological assistance hotline 12356 has received over 700,000 calls, with significant increases in the provision of psychological and sleep outpatient services, up 17% and 39% respectively compared to the same period in 2024 [3] Group 3: Medical Testing and Imaging - Over 200 mutual recognition projects for medical testing results have been established among local medical institutions, with 25 provinces having developed provincial-level imaging cloud services, facilitating over 350 million retrievals [4] Group 4: Childcare Services - The number of childcare spots for children under three years old has reached 4.73 per 1,000 population, with over 890,000 new inclusive childcare spots added, and a 29% average decrease in full-day childcare costs [5] Group 5: Dialysis Services - All counties with a population exceeding 100,000 now provide blood dialysis services, with 2.826 million patient visits recorded in counties with previously weak dialysis capabilities [6] Group 6: Refund of Prepaid Medical Fees - Approximately 9 billion yuan in prepaid outpatient fees have been refunded by public hospitals, affecting around 140 million personal accounts, following the cancellation of the outpatient prepayment system [7][8] Group 7: Blood Donation and Fee Waivers - An online platform for cross-province blood fee waivers has been established, processing over 20,000 applications, ensuring that blood donors can access fee waivers regardless of location [8] Group 8: Health Knowledge Dissemination - The National Health Commission has organized 23 health knowledge release conferences focused on seasonal health topics, aiming to enhance public access to health education and information [9]

Core Viewpoint - The article discusses the importance of providing healthcare support for Chinese employees working abroad as part of the Belt and Road Initiative, highlighting the efforts of the General Technology Group and its subsidiary, Baoshihua International Medical Health Company, in establishing a comprehensive overseas health保障体系 [1][3]. Group 1: Challenges Faced by Chinese Enterprises Abroad - Chinese enterprises face a "health dilemma" when operating overseas, which includes managing safety and social responsibilities while dealing with uneven distribution of medical resources and insufficient emergency medical response [3]. - The presence of multiple health risks, such as infectious diseases and complex working environments, poses a constant threat to the health and safety of overseas employees [3]. Group 2: Services and Achievements of Baoshihua International - Baoshihua International has served over 74 overseas institutions and nearly 100,000 Chinese employees, establishing a health defense line for them [4]. - During the global pandemic, the company successfully repatriated 12,000 Chinese employees and received multiple commendations for its efforts [4]. Group 3: Strategic Development and Future Plans - The company is focused on high-quality and stable development during the 14th Five-Year Plan period, with a core structure based on "two platforms and four business lines" [5]. - Baoshihua International aims to enhance its overseas medical service capabilities and expand international medical cooperation through its platforms [5]. - The company is also developing advanced medical services, including cross-border air medical rescue and innovative health management projects, to ensure the safety of employees in critical conditions [5]. Group 4: Commitment to Quality and Collaboration - Baoshihua International emphasizes the principle of "benevolence as the foundation, quality of state-owned enterprises" and aims to improve comprehensive medical health service capabilities for Chinese enterprises abroad [6]. - The company seeks to integrate into the international medical community and learn from peers to build a collaborative ecosystem for "products + services + standards" [6].

Core Insights - The 2025 Guangdong-Hong Kong-Macao Greater Bay Area Low Altitude Economy High-Quality Development Conference showcased the first "hospital + community health + blood station" integrated low-altitude smart medical transportation network, developed by Fengyi Technology in collaboration with local healthcare institutions [1][3] Group 1: Low Altitude Smart Medical Transportation Network - The network centers around Longgang Central Hospital, with 29 community health centers as nodes and the Longgang Blood Station as a support point, utilizing drones for efficient and safe transportation of medical supplies [3] - As of December 1, the project has completed over 5,000 flights, transporting more than 100,000 medical samples, and has established 10 flight routes covering all 29 community health centers [4] Group 2: Technological Integration and Efficiency - The integration of the iCube laboratory information system allows real-time tracking of sample status, achieving a digital closed-loop management from sample collection to laboratory testing, thus optimizing turnaround time and improving testing quality [4] - The use of drones has significantly reduced the time for blood product transportation, with delivery times cut by over 50%, enhancing the efficiency of emergency medical responses [8] Group 3: Broader Impact and Future Developments - Fengyi Technology's drones have flown over one million flights and can transport between 5 kg to 50 kg over distances of 10 km to 110 km, covering various terrains and meeting high demands for medical logistics [9] - The company aims to continue developing the low-altitude medical transportation network, promoting standardization, scalability, and intelligence in low-altitude logistics to enhance healthcare service delivery [9]

转自：北京日报客户端 北京协和医院国际医疗部（东单院区）八个联合门诊近日开诊，涵盖体重管理、肿瘤基因解读、肺结节 等多个常见热点疑难领域。患者可通过官方渠道便捷预约，享受"一站式"多学科专家诊疗服务，实现复 杂病症的"一步到位"精准诊疗。 传统医疗模式下，面对复杂健康问题，往往需要患者穿梭于不同科室之间，耗时费力且缺乏诊疗连贯 性。北京协和医院国际医疗部（东单院区）在已有的体重管理联合门诊和肿瘤基因解读门诊基础上，聚 焦需要多科协同诊疗的疾病，新增肺结节、牙周正畸、慢性咳嗽、睡眠呼吸、功能性胃肠病、肝胆胰疾 病六个联合门诊，推动服务模式向"以病人为中心"转型。 | 医学科 | | | --- | --- | | | 国际医疗(呼吸内科) | | 国际医疗体重管理 | 国际医疗 (肾内科) | | 联合门诊 | | | | 国际医疗(消化内科) | | 国际医疗肿瘤基因 | | | 解读联合门诊 | 国际医疗(心内科) | | 国际医疗肺结节联 | 国际医疗 (老年医学科) | | 合门诊 | | | | 国际医疗(全科医学科普通 | | | 内科) | | 国际医疗牙周-正畸 | | | 联合门诊 | 国际医 ...

Group 1 - The strategic cooperation between Shanxi Provincial People's Hospital and Huawei aims to integrate resources and advance the application of "technology + scenarios" in healthcare [2][4] - The collaboration will focus on developing replicable and promotable smart medical solutions tailored to the province's needs, establishing a leading smart hospital demonstration project in China [4][11] - Huawei will leverage its technological advantages in artificial intelligence and experience in digital transformation to support the hospital's transition, setting a benchmark for high-quality development in public hospitals in Shanxi and North China [6][9] Group 2 - The partnership will emphasize areas such as medical AI, health big data, research platforms, digital infrastructure, and a unified digital platform for multiple hospital zones, accelerating the innovative application of AI and big data in healthcare [9][11] - The signing of the cooperation agreement marks a new strategic phase driven by technological innovation in medical transformation, aiming to enhance efficiency and service optimization through shared technological advancements [11]

【导读】百花医药或易主，自12月29日开市起停牌 2024年12月2日，米在齐、米恩华、杨小玲及其一致行动人李建城签署《一致行动人协议书》，有效期 一年，合计持有百花医药24.58%的股份。 中国基金报记者 闻言 12月26日晚间，百花医药发布公告称，公司控股股东、实际控制人米在齐、米恩华、杨小玲正在筹划公 司股份协议转让事宜，可能导致公司控制权发生变更。 百花医药计划自12月29日开市起停牌，预计停牌时间不超过2个交易日。12月26日收盘，百花医药股价 报12.24元/股，涨幅达5.88%，总市值为47.07亿元。 筹划股份转让前解除一致行动关系 公告显示，2025年12月1日，米在齐、米恩华、杨小玲及其一致行动人李建城确认不再续签《一致行动 人协议书》，一致行动关系自动解除。 如今，米在齐、米恩华、杨小玲仍为百花医药控股股东、实际控制人，李建城不再是百花医药控股股 东、实际控制人之一致行动人，其所持百花医药股份不再合并计算。 米在齐是米恩华、杨小玲夫妇之子。截至2025年12月1日，米在齐、米恩华、杨小玲合计持有百花医药 20.68%的股份。 具体来看，米在齐、米恩华、杨小玲直接持有百花医药股份的比例分别 ...

【导读】百花医药或易主，自 12 月 29 日开市起停牌 中国基金报记者 闻言 12 月 26 日晚间，百花医药发布公告称，公司控股股东、实际控制人米在齐、米恩华、杨小 玲正在筹划公司股份协议转让事宜，可能导致公司控制权发生变更。 2024 年 12 月 2 日，米在齐、米恩华、杨小玲及其一致行动人李建城签署《一致行动人协 议书》，有效期一年，合计持有百花医药 24.58% 的股份。 百花医药计划自 12 月 29 日开市起停牌，预计停牌时间不超过 2 个交易日。 12 月 26 日 收盘，百花医药股价报 12.24 元 / 股，涨幅达 5.88% ，总市值为 47.07 亿元。 筹划股份转让前解除一致行动关系 公告显示， 2025 年 12 月 1 日，米在齐、米恩华、杨小玲及其一致行动人李建城确认不再 续签《一致行动人协议书》，一致行动关系自动解除。 如今，米在齐、米恩华、杨小玲仍为百花医药控股股东、实际控制人，李建城不再是百花医 药控股股东、实际控制人之一致行动人，其所持百花医药股份不再合并计算。 米在齐是米恩华、杨小玲夫妇之子。截至 2025 年 12 月 1 日，米在齐、米恩华、杨小玲合 计持有百花 ...

| | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净流入 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-12-26 | 40.93 0.17% | | -2139.93万 | -13.49% | -693.58万 | -4.37% | 2833.51万 | - 17.86% | | 2025-12-25 | 40.86 | -0.39% | -1366.25万 | -9.81% | 697.95万 | 5.01% | 668.30万 | 4.80% | | 2025-12-24 | 41.02 0.84% | | -865.51万 | -6.83% | -135.55万 | -1.07% | 1001.06万 | 7.90% | | 2025-12-23 | 40.68 -0.83% | | -1464.22万 | -11.77% | -849.09万 | -6.82% | 2313.31万 | 18.59% | | 2025-12-22 | 41.02 -0.70% ...